[Disclosure] ISU PETASYS (007660) – Notice of Annual General Meeting of Shareholders (Correction) / 2025-03-20
[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P44 (Darzalex Biosimilar) in South Korea / 2025-03-20